Home › Funds › Farallon Capital Management › ELEV

Farallon Capital Management position in ELEV

ELEVATION ONCOLOGY INC

Latest position (Q4 2024)3.53M sh
Reported value held$1.98M
Portfolio Weight0.01%
First reportedQ1 2024
Last changeHold

Quarter by quarter

QuarterSharesValueChange
Q1 2024 3.89M $19.94M New
Q2 2024 3.60M $9.72M Reduce
Q3 2024 3.53M $2.12M Reduce
Q4 2024 3.53M $1.98M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding ELEV

No other tracked fund reports a position in ELEV.

All ELEV fund holders →